Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-14 4:30 pm Unchanged | 2009-02-28 | 13D | POINT Biopharma Global Inc. PNT | RA CAPITAL MANAGEMENT LLC | 8,856,018 9.800% | 0 (Unchanged) | Filing History |
| 2021-07-20 4:31 pm Purchase | 2021-07-20 | 13G | POINT Biopharma Global Inc. PNT | RA CAPITAL MANAGEMENT LLC | 8,856,018 9.800% | 8,856,018 (New Position) | Filing History |
| 2021-07-12 4:37 pm Purchase | 2021-06-30 | 13D | POINT Biopharma Global Inc. PNT | SILBER ALLAN C | 8,865,788 9.800% | 8,865,788 (New Position) | Filing History |
| 2021-06-30 4:32 pm Purchase | 2021-06-24 | 13D | Therapeutics Acquisition Corp. RACA | RA CAPITAL MANAGEMENT LLC | 1,098,318 7.800% | 1,098,318 (New Position) | Filing History |
| 2021-05-10 4:08 pm Purchase | 2021-05-04 | 13G | Therapeutics Acquisition Corp. RACA | RIVERVIEW GROUP LLC | 940,000 6.700% | 940,000 (New Position) | Filing History |
| 2021-04-02 10:59 am Purchase | 2021-03-23 | 13G | Therapeutics Acquisition Corp. RACA | SUVRETTA CAPITAL MANAGEMENT LLC | 1,095,400 7.800% | 1,095,400 (New Position) | Filing History |
| 2021-02-16 3:45 pm Purchase | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | PERCEPTIVE ADVISORS LLC | 1,500,000 10.700% | 1,500,000 (New Position) | Filing History |
| 2021-02-16 12:24 pm Purchase | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | PRICE T ROWE ASSOCIATES INC | 921,822 5.200% | 921,822 (New Position) | Filing History |
| 2021-02-12 7:58 pm Sale | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | BIOTECHNOLOGY VALUE FUND L P | 954,996 6.800% | -45,004 (-4.50%) | Filing History |
| 2021-02-12 08:10 am Purchase | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | venBio Select Advisor LLC | 1,000,000 7.100% | 1,000,000 (New Position) | Filing History |
| 2021-02-05 5:51 pm Unchanged | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | BlackRock Inc. BLK | 1,500,000 10.700% | 0 (Unchanged) | Filing History |
| 2021-02-04 10:27 am Purchase | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | WELLINGTON MANAGEMENT GROUP LLP | 877,832 6.250% | 877,832 (New Position) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | FRANKLIN RESOURCES INC BEN | 1,000,000 7.100% | 1,000,000 (New Position) | Filing History |
| 2020-09-09 3:52 pm Purchase | 2020-08-31 | 13G | Therapeutics Acquisition Corp. RACA | BlackRock Inc. BLK | 1,500,000 10.700% | 1,500,000 (New Position) | Filing History |
| 2020-07-20 4:37 pm Purchase | 2020-07-10 | 13G | Therapeutics Acquisition Corp. RACA | Boxer Capital LLC | 1,500,000 8.800% | 1,500,000 (New Position) | Filing History |
| 2020-07-20 4:35 pm Purchase | 2020-07-08 | 13G | Therapeutics Acquisition Corp. RACA | BIOTECHNOLOGY VALUE FUND L P | 1,000,000 5.900% | 1,000,000 (New Position) | Filing History |
| 2020-07-20 4:16 pm Purchase | 2020-07-10 | 13G | Therapeutics Acquisition Corp. RACA | Bain Capital Life Sciences Fund II L.P. | 891,429 6.300% | 891,429 (New Position) | Filing History |